Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 146,215	$ 304,767
Restricted cash	1,574	1,472
Investments	264,455	119,543
Trade receivables	57,667	50,599
Inventory, net	27,033	27,533
Prepaid expenses and other current assets	14,112	12,586
Total current assets	511,056	516,500
Property and equipment, net	8,438	8,617
Long-term investments	3,445	18,077
Other assets	6,946	6,806
Total assets	529,885	550,000
Liabilities and Stockholders’ Deficit
Accounts payable	13,889	14,356
Accrued expenses	75,300	87,565
Deferred revenue	1,779	1,224
Lease financing obligation	2,530	2,369
Total current liabilities	93,498	105,514
Lease financing obligation	5,803	5,804
Royalty financing obligations	526,121	501,655
Secured term loans	293,176	231,624
Stockholders’ deficit:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 189,491 as of June 30, 2023 and 187,906 as of December 31, 2022	1,895	1,879
Additional paid-in capital	1,191,981	1,158,118
Accumulated other comprehensive income	690	26
Accumulated deficit	(1,583,279)	(1,454,620)
Total stockholders’ deficit	(388,713)	(294,597)
Total liabilities and stockholders’ deficit	$ 529,885	$ 550,000

Carrying amount as of the balance sheet date of obligations for future royalties.

No definition available.

Name:	bcrx_FutureRoyaltiesPayable
Namespace Prefix:	bcrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).